OHA
EBS icon

Oak Hill Advisors’s Emergent Biosolutions EBS Stock Holding History

Oak Hill Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.33M Hold
1,113,338
– – 1.33% 8
2026
Q1 		$9.24M Sell
1,113,338
-2,500,000
-69% -$25.9M 1.05% 8
2025
Q4 		$44.7M Hold
3,613,338
– – 7.29% 3
2025
Q3 		$16.6M Hold
3,613,338
– – 3.45% 5
2025
Q2 		$10.9M Buy
3,613,338
+2,500,000
+225% +$14.3M 2.74% 5
2025
Q1 		$5.41M Hold
1,113,338
– – 1.15% 9
2024
Q4 		$10.6M Hold
1,113,338
– – 1.96% 6
2024
Q3 		$9.3M Buy
+1,113,338
New +$10.1M 1.39% 6

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Oak Hill Advisors's EBS Position: Q2 2026 in Review

Oak Hill Advisors held its Emergent Biosolutions (EBS) position steady in Q2 2026 at 1,113,338 shares worth $9.33M. The position accounts for 1.33% of the portfolio, ranked #8.

Oak Hill Advisors first reported a position in EBS in Q3 2024 and has held it in 8 quarters since. The position peaked at $44.7M in Q4 2025. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Oak Hill Advisors held 1,113,338 shares of Emergent Biosolutions worth $9.33M as of Q2 2026.
  • Oak Hill Advisors left its Emergent Biosolutions share count unchanged in Q2 2026.
  • Emergent Biosolutions made up 1.33% of Oak Hill Advisors's portfolio in Q2 2026, its #8 holding.
  • Oak Hill Advisors first reported a position in Emergent Biosolutions in Q3 2024 and has held it in 8 quarters since.
  • Oak Hill Advisors's Emergent Biosolutions position peaked at $44.7M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Oak Hill Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.